Amyotrophic Lateral Sclerosis (ALS)

Home > Flashcards > Print Preview

The flashcards below were created by user brau2308 on FreezingBlue Flashcards. What would you like to do?

  1. What type of disease is ALS?
    motor neuron disease
  2. Motor Neuron Disease
    • progressive bulbar palsy (upper and lower motor neurons)
    • --life expectancy 6 mo to 3 years from diagnosis
    • progressive/spinal muscular atrophy (lower motor neurons of spinal cord and brain stem)
    • --live > 5 years
    • Primary lateral sclerosis (upper motor neurons)
    • --may have normal life expectancy
    • ALS (upper and lower neurons)
    • --most common
    • --life expectancy 2-5 years from diagnosis
  3. ALS description:
    • irreversible, progressive disorder of the nervous system
    • degeneration of both UMN and LMN
    • neurons in the motor cortex and brainstem and anterior horn cells in the spinal cord stop relaying messages to the mm (weakness, atrophy, and fasciculations)
    • loss of voluntary movement, then death
    • the chest and diaphragm mm become involved and the person is no longer able to breathe
    • respiratory failure is leading cause of death
  4. Affect men or women more?
  5. Age of onset:
    55-75, peak 62
  6. amyotrophy:
    atrophy of the muscle fibers as their corresponding anterior horn cells degenerate
  7. Lateral sclerosis:
    hardening of the anterior and lateral columns of the spinal cord as the motor neurons degenerate and are replaced by fibrous astrocytes (gliosis)
  8. Disease Course:
    • onset to ventilator dependence of death is 2-4 years
    • after ventilator mean life expectancy is approx. 5 yrs but can exceed 10
    • skin integrity
  9. Despite the progressive nature of the disease, what functions remain normal?
    • cognition
    • occulomotor
    • sensation
    • bowel/bladder
  10. What is research of ALS focused on?
    finding the source of neuron degeneration and stopping it
  11. Clinical manifestations in LMN:
    • asymmetrical weakness
    • cramping w/ voluntary movement in the early morning
    • fasciculations
    • extensor mm become weaker than flexor mm; hand
  12. Clinical Manifestations UMN:
    • positive babinski
    • positive hoffman's sign
    • hyperreflexivity
  13. Are both LMN and UMN symptoms present?
  14. Pharmacological Management for symptoms:
    • baclofen for spasticity or anticonvulsants (gabapentin or neurotin)
    • NSAIDs for pain
    • Benzodiazepines for severe fasciculations
    • antioxidant rich food may slow impact of ALS
  15. Pharmacological management for disease mechanism:
    • rilusole/rilutek -- increase time until trach or death
    • no improvement of muscle strength or neurological fxn
  16. Indicators for therapy:
    • fatigue
    • spasticity
    • functional losses are noted when isometric strength declines
    • progressive weakness of scapulohumeral musculature and subluxation
    • contractures (need stretching)
    • unable to shift weight for pressure relief (recline schedule)
    • loss of diaphragm (abs to help)
  17. PT
    • slow stretching for spasticity and cramping
    • daily ROM taught to caregivers
    • safe and efficient transfers
    • initially, assistive device for walking w/ AFO for foot drop
    • WC w/ reassess as disease progresses
    • sub-maximal exercise for those w/ slow progression of disease
  18. OT
    • energy conservation
    • assessment and intervention for dysphagia
    • adaptive equipment for meaningful activities
    • -universal cuff for decreased grip
    • -splint or brace into 20-25 degrees of extension to increase grip strength
    • -balanced forearm orthosis
    • -slings/taping to reduce pain due to shoulder girdle weakness
    • -environment control units (eye movements)
  19. Most importantly:
    • understand the wants and needs of the person
    • anticipate the progressive nature of this disease
    • problem solve w/ them to determine how you can best assist them; including making recommendations for AT
    • understand and appreciate the impact of the environment to help them remain as functional for as long as possible
    • work w/ caregiver and other providers

Card Set Information

Amyotrophic Lateral Sclerosis (ALS)
2014-05-03 22:36:18

review of ALS lecture 4/23
Show Answers:

What would you like to do?

Home > Flashcards > Print Preview